Literature DB >> 1416899

Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.

R Horn1, J Lavallée, H G Robson.   

Abstract

The susceptibilities of 200 clinical isolates of the Bacteroides fragilis group to 11 antimicrobial agents were determined by the broth microdilution method of the National Committee for Clinical Laboratory Standards. All isolates were susceptible to imipenem and ticarcillin-clavulanic acid. The rates of resistance to cefoxitin and clindamycin were low (4 and 6%, respectively), while those to ceftizoxime and cefotetan were higher (10.5 and 24%, respectively).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416899      PMCID: PMC192437          DOI: 10.1128/AAC.36.9.2051

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Resistance of anaerobic bacteria to antimicrobial agents.

Authors:  M T Peláez; E Cercenado; M Rodríguez-Créixems; E Bouza
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

Authors:  K Lee; I H Jang; Y J Kim; Y Chong
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.

Authors:  K E Aldridge; H M Wexler; C V Sanders; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

4.  In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.

Authors:  I Brook
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

5.  Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.

Authors:  M D Appleman; P N Heseltine; C E Cherubin
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

6.  Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors:  C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

7.  Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors:  G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

9.  Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.

Authors:  S Hurlbut; G J Cuchural; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

10.  Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.

Authors:  J E García-Rodríguez; J E García-Sánchez
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb
View more
  4 in total

1.  Adjunctive antimicrobial therapy for complicated appendicitis: bacterial overkill by combination therapy.

Authors:  J A Hopkins; S E Wilson; D G Bobey
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

Review 2.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.

Authors:  P Turgeon; V Turgeon; M Gourdeau; J Dubois; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 4.  Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.

Authors:  Geisla Mary Silva Soares; Luciene Cristina Figueiredo; Marcelo Faveri; Sheila Cavalca Cortelli; Poliana Mendes Duarte; Magda Feres
Journal:  J Appl Oral Sci       Date:  2012 May-Jun       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.